Logo image of JEN.BR

JENSEN-GROUP NV (JEN.BR) Stock Fundamental Analysis

EBR:JEN - Euronext Brussels - BE0003858751 - Common Stock - Currency: EUR

48  +1.1 (+2.35%)

Fundamental Rating

7

JEN gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 105 industry peers in the Machinery industry. JEN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. JEN is not valued too expensively and it also shows a decent growth rate. These ratings could make JEN a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year JEN was profitable.
JEN had a positive operating cash flow in the past year.
Each year in the past 5 years JEN has been profitable.
JEN had a positive operating cash flow in 4 of the past 5 years.
JEN.BR Yearly Net Income VS EBIT VS OCF VS FCFJEN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

1.2 Ratios

JEN has a Return On Assets of 7.63%. This is amongst the best in the industry. JEN outperforms 88.46% of its industry peers.
The Return On Equity of JEN (13.29%) is better than 76.92% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.69%, JEN belongs to the top of the industry, outperforming 82.69% of the companies in the same industry.
JEN had an Average Return On Invested Capital over the past 3 years of 8.60%. This is in line with the industry average of 8.45%.
The last Return On Invested Capital (10.69%) for JEN is above the 3 year average (8.60%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.63%
ROE 13.29%
ROIC 10.69%
ROA(3y)5.37%
ROA(5y)4.9%
ROE(3y)10.36%
ROE(5y)9.68%
ROIC(3y)8.6%
ROIC(5y)8.15%
JEN.BR Yearly ROA, ROE, ROICJEN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

The Profit Margin of JEN (8.54%) is better than 87.50% of its industry peers.
In the last couple of years the Profit Margin of JEN has grown nicely.
JEN has a better Operating Margin (10.68%) than 82.69% of its industry peers.
In the last couple of years the Operating Margin of JEN has grown nicely.
JEN has a worse Gross Margin (12.70%) than 86.54% of its industry peers.
JEN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.68%
PM (TTM) 8.54%
GM 12.7%
OM growth 3Y22.68%
OM growth 5Y5.32%
PM growth 3Y35.75%
PM growth 5Y6.89%
GM growth 3Y18.27%
GM growth 5Y3.68%
JEN.BR Yearly Profit, Operating, Gross MarginsJEN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so JEN is still creating some value.
JEN has more shares outstanding than it did 1 year ago.
JEN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for JEN has been reduced compared to a year ago.
JEN.BR Yearly Shares OutstandingJEN.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
JEN.BR Yearly Total Debt VS Total AssetsJEN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

JEN has an Altman-Z score of 3.48. This indicates that JEN is financially healthy and has little risk of bankruptcy at the moment.
JEN has a Altman-Z score of 3.48. This is amongst the best in the industry. JEN outperforms 85.58% of its industry peers.
JEN has a debt to FCF ratio of 1.91. This is a very positive value and a sign of high solvency as it would only need 1.91 years to pay back of all of its debts.
The Debt to FCF ratio of JEN (1.91) is better than 85.58% of its industry peers.
JEN has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
JEN's Debt to Equity ratio of 0.12 is amongst the best of the industry. JEN outperforms 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.91
Altman-Z 3.48
ROIC/WACC1.48
WACC7.21%
JEN.BR Yearly LT Debt VS Equity VS FCFJEN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 2.01 indicates that JEN has no problem at all paying its short term obligations.
JEN has a Current ratio of 2.01. This is in the better half of the industry: JEN outperforms 75.00% of its industry peers.
A Quick Ratio of 1.59 indicates that JEN should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.59, JEN belongs to the best of the industry, outperforming 82.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 1.59
JEN.BR Yearly Current Assets VS Current LiabilitesJEN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.97% over the past year.
JEN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.71% yearly.
The Revenue has grown by 11.56% in the past year. This is quite good.
Measured over the past years, JEN shows a small growth in Revenue. The Revenue has been growing by 3.08% on average per year.
EPS 1Y (TTM)29.97%
EPS 3Y51.5%
EPS 5Y6.71%
EPS Q2Q%17.12%
Revenue 1Y (TTM)11.56%
Revenue growth 3Y17.72%
Revenue growth 5Y3.08%
Sales Q2Q%9.97%

3.2 Future

JEN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.66% yearly.
Based on estimates for the next years, JEN will show a small growth in Revenue. The Revenue will grow by 6.58% on average per year.
EPS Next Y33.33%
EPS Next 2Y19.24%
EPS Next 3Y14.06%
EPS Next 5Y6.66%
Revenue Next Year10.8%
Revenue Next 2Y10.5%
Revenue Next 3Y8.26%
Revenue Next 5Y6.58%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JEN.BR Yearly Revenue VS EstimatesJEN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
JEN.BR Yearly EPS VS EstimatesJEN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

JEN is valuated correctly with a Price/Earnings ratio of 12.77.
Based on the Price/Earnings ratio, JEN is valued a bit cheaper than 74.04% of the companies in the same industry.
JEN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.35.
Based on the Price/Forward Earnings ratio of 9.86, the valuation of JEN can be described as reasonable.
Based on the Price/Forward Earnings ratio, JEN is valued a bit cheaper than 77.88% of the companies in the same industry.
JEN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 12.77
Fwd PE 9.86
JEN.BR Price Earnings VS Forward Price EarningsJEN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

JEN's Enterprise Value to EBITDA ratio is in line with the industry average.
JEN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 19.16
EV/EBITDA 9.13
JEN.BR Per share dataJEN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

JEN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JEN has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as JEN's earnings are expected to grow with 14.06% in the coming years.
PEG (NY)0.38
PEG (5Y)1.9
EPS Next 2Y19.24%
EPS Next 3Y14.06%

3

5. Dividend

5.1 Amount

JEN has a Yearly Dividend Yield of 1.12%. Purely for dividend investing, there may be better candidates out there.
JEN's Dividend Yield is comparable with the industry average which is at 3.07.
Compared to an average S&P500 Dividend Yield of 2.33, JEN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.12%

5.2 History

The dividend of JEN decreases each year by -2.37%.
Dividend Growth(5Y)-2.37%
Div Incr Years1
Div Non Decr Years3
JEN.BR Yearly Dividends per shareJEN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

JEN pays out 19.85% of its income as dividend. This is a sustainable payout ratio.
DP19.85%
EPS Next 2Y19.24%
EPS Next 3Y14.06%
JEN.BR Yearly Income VS Free CF VS DividendJEN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M 30M
JEN.BR Dividend Payout.JEN.BR Dividend Payout, showing the Payout Ratio.JEN.BR Dividend Payout.PayoutRetained Earnings

JENSEN-GROUP NV

EBR:JEN (3/7/2025, 7:00:00 PM)

48

+1.1 (+2.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-06 2025-03-06/amc
Earnings (Next)05-19 2025-05-19
Inst Owners9.17%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap462.24M
Analysts80
Price Target51 (6.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.12%
Yearly Dividend0.44
Dividend Growth(5Y)-2.37%
DP19.85%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)18.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.32%
Valuation
Industry RankSector Rank
PE 12.77
Fwd PE 9.86
P/S 1.1
P/FCF 19.16
P/OCF 15.16
P/B 1.71
P/tB 1.91
EV/EBITDA 9.13
EPS(TTM)3.76
EY7.83%
EPS(NY)4.87
Fwd EY10.14%
FCF(TTM)2.5
FCFY5.22%
OCF(TTM)3.17
OCFY6.6%
SpS43.69
BVpS28.07
TBVpS25.12
PEG (NY)0.38
PEG (5Y)1.9
Profitability
Industry RankSector Rank
ROA 7.63%
ROE 13.29%
ROCE 14.08%
ROIC 10.69%
ROICexc 12.35%
ROICexgc 13.77%
OM 10.68%
PM (TTM) 8.54%
GM 12.7%
FCFM 5.73%
ROA(3y)5.37%
ROA(5y)4.9%
ROE(3y)10.36%
ROE(5y)9.68%
ROIC(3y)8.6%
ROIC(5y)8.15%
ROICexc(3y)10.88%
ROICexc(5y)10.72%
ROICexgc(3y)12.72%
ROICexgc(5y)12.05%
ROCE(3y)11.33%
ROCE(5y)10.73%
ROICexcg growth 3Y17.79%
ROICexcg growth 5Y-4.33%
ROICexc growth 3Y15.32%
ROICexc growth 5Y-5.52%
OM growth 3Y22.68%
OM growth 5Y5.32%
PM growth 3Y35.75%
PM growth 5Y6.89%
GM growth 3Y18.27%
GM growth 5Y3.68%
F-Score7
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.91
Debt/EBITDA 0.62
Cap/Depr 104.76%
Cap/Sales 1.51%
Interest Coverage 93
Cash Conversion 59.79%
Profit Quality 67.13%
Current Ratio 2.01
Quick Ratio 1.59
Altman-Z 3.48
F-Score7
WACC7.21%
ROIC/WACC1.48
Cap/Depr(3y)122.12%
Cap/Depr(5y)106.39%
Cap/Sales(3y)2.47%
Cap/Sales(5y)2.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.97%
EPS 3Y51.5%
EPS 5Y6.71%
EPS Q2Q%17.12%
EPS Next Y33.33%
EPS Next 2Y19.24%
EPS Next 3Y14.06%
EPS Next 5Y6.66%
Revenue 1Y (TTM)11.56%
Revenue growth 3Y17.72%
Revenue growth 5Y3.08%
Sales Q2Q%9.97%
Revenue Next Year10.8%
Revenue Next 2Y10.5%
Revenue Next 3Y8.26%
Revenue Next 5Y6.58%
EBIT growth 1Y45.86%
EBIT growth 3Y44.43%
EBIT growth 5Y8.57%
EBIT Next Year51.22%
EBIT Next 3Y20.09%
EBIT Next 5Y20.08%
FCF growth 1Y17008.5%
FCF growth 3Y-27.94%
FCF growth 5YN/A
OCF growth 1Y206.22%
OCF growth 3Y-17.94%
OCF growth 5YN/A